glycosmedia.com Report : Visit Site


  • Ranking Alexa Global: # 4,359,821

    Server:Apache...

    The main IP address: 84.18.207.67,Your server United Kingdom,Belfast ISP:Catalyst2 Shared Hosting Network  TLD:com CountryCode:GB

    The description :these data support two clear phases of c-peptide decline: an initial exponential fall over a 7-year period, followed by a prolonged stabilization where c-peptide levels no longer decline. understandin...

    This report updates in 26-Jun-2018

Created Date:2008-05-14
Changed Date:2017-04-14
Expires Date:2018-05-14

Technical data of the glycosmedia.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host glycosmedia.com. Currently, hosted in United Kingdom and its service provider is Catalyst2 Shared Hosting Network .

Latitude: 54.58332824707
Longitude: -5.9333300590515
Country: United Kingdom (GB)
City: Belfast
Region: Northern Ireland
ISP: Catalyst2 Shared Hosting Network

the related websites

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

Transfer-Encoding:chunked
Keep-Alive:timeout=5, max=99
Server:Apache
Connection:Keep-Alive
Link:; rel="https://api.w.org/"
Date:Mon, 25 Jun 2018 19:16:40 GMT
Content-Type:text/html; charset=UTF-8

DNS

soa:ns5.catalyst2.net. dnsadmin.breadfruit.shared.hosting.catalyst2.com. 2016022201 3600 7200 1209600 86400
txt:"v=spf1 a mx ip4:84.18.207.67 ?all"
ns:ns6.catalyst2.net.
ns5.catalyst2.net.
ipv4:IP:84.18.207.67
ASN:29636
OWNER:CATALYST2-AS, IE
Country:GB
mx:MX preference = 100, mail exchanger = lin-mx100.hosting.catalyst2.com.
MX preference = 0, mail exchanger = glycosmedia.com.

HtmlToText

glycosmedia diabetes news service privacy & cookies: this site uses cookies. by continuing to use this website, you agree to their use. to find out more, including how to control cookies, see here: cookies policy news archive categories & tags journal watch updates education reviews about us ▼ about glycosmedia editorial team frequently asked questions comments press releases disclaimer subscribe contact diabetes news glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals. c-peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase june 24th 2018 these data support two clear phases of c-peptide decline: an initial exponential fall over a 7-year period, followed by a prolonged stabilization where c-peptide levels no longer decline. understanding the pathophysiological and immunological differences between these two phases will give crucial insights into understanding β-cell survival (diabetes care) categories: news , pathology tags: c-peptide , type 1 diabetes categories: pathology tags: c-peptide , type 1 diabetes association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus june 24th 2018 our findings suggest that sglt-2i reduced hhf compared with dpp-4i. a heart failure protective effect of sglt-2i use vs. dpp-4i use was shown 30 days after initiating the sglt-2i among patients with established cvd, but this effect appeared later in patients without established cvd (cardiovascular diabetology) categories: cardiovascular , news tags: sglt2 inhibitors , type 2 diabetes categories: cardiovascular tags: sglt2 inhibitors , type 2 diabetes cardiovascular outcome studies in type 2 diabetes : comparison between sglt2 inhibitors and glp-1 receptor agonists june 24th 2018 currently, there is a paradigm shift in t2dm management, moving from a primary objective of glucose control to a cardiovascular and renal protection (diabetes research and clinical practice) categories: medication , news tags: glp1 , sglt2 inhibitors categories: medication tags: glp1 , sglt2 inhibitors the gut microbiome as a target for the treatment of type 2 diabetes june 22nd 2018 the studies discussed in this review suggest that individuals who are obese are likely to have an imbalance in gut microbiota composition and a ‘gut signature’ varying with metabolic control (current diabetes reports) categories: diet tags: microbiota , type 2 diabetes cardiovascular safety of glp-1 receptor agonists for diabetes patients with high cardiovascular risk: a meta-analysis of cardiovascular outcomes trials june 21st 2018 additional glp-1 receptor agonists treatment did not increase cardiovascular outcomes in diabetes patients with high cardiovascular risk or established cardiovascular disease (diabetes research and clinical practice) categories: medication , news tags: glp-1 receptor agonists categories: medication tags: glp-1 receptor agonists lipid‐lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes june 21st 2018 in a population of patients with type 2 diabetes with a variety of risk profiles, use of lipid‐lowering medication reduced the risk of dr and thus the risks involved in treatment with laser photocoagulation and vitrectomy (diabetes, obesity and metabolism) categories: news , ophthalmology tags: lipid , retinopathy , type 2 diabetes categories: ophthalmology tags: lipid , retinopathy , type 2 diabetes confocal microscopy of corneal nerve plexus as an early marker of eye involvement in patients with type 2 diabetes june 21st 2018 cnl and cnt changes are evident even in the early stages of dm, and rnfl reduction was recorded in the temporal quadrants. these findings indicate that, in the eye with diabetes, neuropathy may represent an early marker of the disease (diabetes research and clinical practice) categories: news , ophthalmology tags: type 2 diabetes categories: ophthalmology tags: type 2 diabetes high proportion of type 2 diabetes adults with poor glycated hemoglobin perceived that their diabetes control was “excellent” june 21st 2018 this study demonstrates discordance between perception of diabetes control and hba1c which may hinder effective diabetes care (canadian journal of diabetes) categories: monitoring , news tags: hba1c , type 2 diabetes categories: monitoring tags: hba1c , type 2 diabetes for patients with type 2 diabetes, what’s the best target hemoglobin a1c? june 19th 2018 the acp set its target higher than recommended by other prominent health groups. the american diabetes association (ada) generally recommends an hba1c goal of less than 7%, while the american association of clinical endocrinologists (aace) advises even tighter control of 6.5% or lower if it can be achieved safely (jama) categories: news , treatment tags: hba1c , type 2 diabetes categories: treatment tags: hba1c , type 2 diabetes extracellular vesicles: a novel target for exercise-mediated reductions in type 2 diabetes and cardiovascular disease risk june 19th 2018 we present the novel hypothesis that extracellular vesicles (evs) are candidate biomarkers that may relate to impaired endothelial function and insulin resistance independent of obesity risk factors (journal of diabetes research) categories: news , pathology tags: extracellular vesicles , type 2 diabetes categories: pathology tags: extracellular vesicles , type 2 diabetes dietary and nutritional approaches for prevention and management of type 2 diabetes june 18th 2018 in this article, we examine the evidence for areas of consensus as well as ongoing uncertainty or controversy about dietary guidelines for type 2 diabetes. what is the best dietary approach? is it possible to achieve remission of type 2 diabetes with lifestyle behaviour changes or is it inevitably a condition causing progressive health decline? (bmj) categories: diet , news tags: type 2 diabetes categories: diet tags: type 2 diabetes dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (award-7) june 15th 2018 in patients with type 2 diabetes and moderate-to-severe chronic kidney disease, once-weekly dulaglutide produced glycaemic control similar to that achieved with insulin glargine, with reduced decline in egfr. dulaglutide seems to be safe to use to achieve glycaemic control in patients with moderate-to-severe chronic kidney disease (the lancet diabetes & endocrinology) categories: neuropathy , news tags: dulaglutide , glargine , insulin , type 2 diabetes categories: neuropathy tags: dulaglutide , glargine , insulin , type 2 diabetes national diabetes audit – insulin pump report 2016-17 june 15th 2018 report for people with type 1 diabetes on an insulin pump at national, lhb, and hospital/trust level for the audit period 2016-17 (nhs digital) categories: audits , news tags: insulin pump categories: audits tags: insulin pump clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis june 14th 2018 neither the rate of administration nor the sodium chloride content of intravenous fluids significantly influenced neurologic outcomes in children with diabetic ketoacidosis (nejm) categories: news , treatment tags: dka , pediatric categories: treatment tags: dka , pediatric a randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/ml versus 100 units/ml in older people with type 2 diabetes: results from the senior study june 13th 2018 efficacy and safety of gla-300 was demonstrated in older people (≥65 years of age) with type 2 diabetes, with comparable reductions in hba1c and similarly low or lower risk of documented symptomatic hypoglycemia versus gla-100. a significant benefit in hypoglycemia reduction was seen i

URL analysis for glycosmedia.com


http://www.glycosmedia.com/tag/cgm/
http://www.glycosmedia.com/news/page/2/
http://www.glycosmedia.com/news/screening/
http://www.glycosmedia.com/tag/pregnancy/
http://www.glycosmedia.com/tag/exenatide/
http://www.glycosmedia.com/tag/heel-fissure/
http://www.glycosmedia.com/news/podiatry/
http://www.glycosmedia.com/tag/insulin/
http://www.glycosmedia.com/news/neuropathy/
http://www.glycosmedia.com/news/prevention/
http://www.glycosmedia.com/tag/nice/
http://www.glycosmedia.com/news/diagnosis/
http://www.glycosmedia.com/tag/microbiota/
http://www.glycosmedia.com/tag/ogtt/
http://www.glycosmedia.com/news/biochemistry/
amgen.co.uk
invokana.co.uk
weds-wales.co.uk
digital.nhs.uk
medicines.astrazeneca.co.uk
diabetesmatters.co.uk
freestylediabetes.co.uk

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;


Whois Server Version 2.0

Domain names in the .com and .net domains can now be registered
with many different competing registrars. Go to http://www.internic.net
for detailed information.

Domain Name: GLYCOSMEDIA.COM
Registrar: TUCOWS DOMAINS INC.
Sponsoring Registrar IANA ID: 69
Whois Server: whois.tucows.com
Referral URL: http://www.tucowsdomains.com
Name Server: NS5.CATALYST2.NET
Name Server: NS6.CATALYST2.NET
Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Updated Date: 14-apr-2017
Creation Date: 14-may-2008
Expiration Date: 14-may-2018

>>> Last update of whois database: 2017-07-19T02:59:34Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR TUCOWS DOMAINS INC.

  REFERRER http://www.tucowsdomains.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =glycosmedia.com

  PORT 43

  SERVER whois.tucows.com

  ARGS glycosmedia.com

  PORT 43

  TYPE domain

DOMAIN

  NAME glycosmedia.com

NSERVER

  NS5.CATALYST2.NET 84.18.207.222

  NS6.CATALYST2.NET 185.28.164.100

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2017-04-14

  CREATED 2008-05-14

  EXPIRES 2018-05-14

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.uglycosmedia.com
  • www.7glycosmedia.com
  • www.hglycosmedia.com
  • www.kglycosmedia.com
  • www.jglycosmedia.com
  • www.iglycosmedia.com
  • www.8glycosmedia.com
  • www.yglycosmedia.com
  • www.glycosmediaebc.com
  • www.glycosmediaebc.com
  • www.glycosmedia3bc.com
  • www.glycosmediawbc.com
  • www.glycosmediasbc.com
  • www.glycosmedia#bc.com
  • www.glycosmediadbc.com
  • www.glycosmediafbc.com
  • www.glycosmedia&bc.com
  • www.glycosmediarbc.com
  • www.urlw4ebc.com
  • www.glycosmedia4bc.com
  • www.glycosmediac.com
  • www.glycosmediabc.com
  • www.glycosmediavc.com
  • www.glycosmediavbc.com
  • www.glycosmediavc.com
  • www.glycosmedia c.com
  • www.glycosmedia bc.com
  • www.glycosmedia c.com
  • www.glycosmediagc.com
  • www.glycosmediagbc.com
  • www.glycosmediagc.com
  • www.glycosmediajc.com
  • www.glycosmediajbc.com
  • www.glycosmediajc.com
  • www.glycosmedianc.com
  • www.glycosmedianbc.com
  • www.glycosmedianc.com
  • www.glycosmediahc.com
  • www.glycosmediahbc.com
  • www.glycosmediahc.com
  • www.glycosmedia.com
  • www.glycosmediac.com
  • www.glycosmediax.com
  • www.glycosmediaxc.com
  • www.glycosmediax.com
  • www.glycosmediaf.com
  • www.glycosmediafc.com
  • www.glycosmediaf.com
  • www.glycosmediav.com
  • www.glycosmediavc.com
  • www.glycosmediav.com
  • www.glycosmediad.com
  • www.glycosmediadc.com
  • www.glycosmediad.com
  • www.glycosmediacb.com
  • www.glycosmediacom
  • www.glycosmedia..com
  • www.glycosmedia/com
  • www.glycosmedia/.com
  • www.glycosmedia./com
  • www.glycosmediancom
  • www.glycosmedian.com
  • www.glycosmedia.ncom
  • www.glycosmedia;com
  • www.glycosmedia;.com
  • www.glycosmedia.;com
  • www.glycosmedialcom
  • www.glycosmedial.com
  • www.glycosmedia.lcom
  • www.glycosmedia com
  • www.glycosmedia .com
  • www.glycosmedia. com
  • www.glycosmedia,com
  • www.glycosmedia,.com
  • www.glycosmedia.,com
  • www.glycosmediamcom
  • www.glycosmediam.com
  • www.glycosmedia.mcom
  • www.glycosmedia.ccom
  • www.glycosmedia.om
  • www.glycosmedia.ccom
  • www.glycosmedia.xom
  • www.glycosmedia.xcom
  • www.glycosmedia.cxom
  • www.glycosmedia.fom
  • www.glycosmedia.fcom
  • www.glycosmedia.cfom
  • www.glycosmedia.vom
  • www.glycosmedia.vcom
  • www.glycosmedia.cvom
  • www.glycosmedia.dom
  • www.glycosmedia.dcom
  • www.glycosmedia.cdom
  • www.glycosmediac.om
  • www.glycosmedia.cm
  • www.glycosmedia.coom
  • www.glycosmedia.cpm
  • www.glycosmedia.cpom
  • www.glycosmedia.copm
  • www.glycosmedia.cim
  • www.glycosmedia.ciom
  • www.glycosmedia.coim
  • www.glycosmedia.ckm
  • www.glycosmedia.ckom
  • www.glycosmedia.cokm
  • www.glycosmedia.clm
  • www.glycosmedia.clom
  • www.glycosmedia.colm
  • www.glycosmedia.c0m
  • www.glycosmedia.c0om
  • www.glycosmedia.co0m
  • www.glycosmedia.c:m
  • www.glycosmedia.c:om
  • www.glycosmedia.co:m
  • www.glycosmedia.c9m
  • www.glycosmedia.c9om
  • www.glycosmedia.co9m
  • www.glycosmedia.ocm
  • www.glycosmedia.co
  • glycosmedia.comm
  • www.glycosmedia.con
  • www.glycosmedia.conm
  • glycosmedia.comn
  • www.glycosmedia.col
  • www.glycosmedia.colm
  • glycosmedia.coml
  • www.glycosmedia.co
  • www.glycosmedia.co m
  • glycosmedia.com
  • www.glycosmedia.cok
  • www.glycosmedia.cokm
  • glycosmedia.comk
  • www.glycosmedia.co,
  • www.glycosmedia.co,m
  • glycosmedia.com,
  • www.glycosmedia.coj
  • www.glycosmedia.cojm
  • glycosmedia.comj
  • www.glycosmedia.cmo
Show All Mistakes Hide All Mistakes